FDA Adverse Event Death Summary report: N

TAXUS EXPRESS2 PACLITAXEL-ELUTING CORONARY STENT

MDR report key: 689014 · Received March 15, 2006

Report

Report Number
6000093-2006-00392
Event Type
Death
Date Received
March 15, 2006
Date of Event
August 12, 2005
Report Date
February 15, 2006
Manufacturer
BOSTON SCIENTIFIC
Product Code
NIQ
Removal / Correction Number
NA
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
TX, US
Reporter Occupation
OTHER

Narratives

Description of Event or Problem · 1

CLINICAL STUDY : SAME CASE AS 600093-2006-00391,600093-2006-00392. IT WAS REPORTED THAT 246 DAYS AFTER A CORONARY ARTERY DRUG ELUTING STENTING PROCEDURE THE PATIENT EXPIRED. TARGET LESION 1 SAS A 2.5MM, 90% STENOSED PORTION OF THE DISTAL RIGHT CORONARY ARTERY (DIST RCA). THE PHYSICIAN TREATED THE LESION WITH PREDILATATION AND SUCCESSFUL PLACEMENT OF A TAXUS EXPRESS2 8.8% 2.50X16MM DRUG ELUTING STENT IN THE TARGET LESION. LESION 2 WAS A 2.5MM, 90% STENOSED PORTION OF THE RIGHT POSTERIOR DESCENDING ARTERY (R-PDA). THE PHYSICIAN TREATED THE LESSION WITH PREDILATATION AND SUCCESSFUL PLACEMENT OF A TAXUS EXPRESS3 8.8% 2.50X16MM DRUG ELUTING STENT IN THE TARGET LESION. LESION 3 WAS A 2.5MM, 95% STENOSED PORTION OF THE 1ST OBTUSE MARGINAL (1ST OB MARG). THE PHYSICIAN TREATED THE LESION WITH PREDILATATION AND SUCCESSFUL PLACEMENT OF A TAXUS EXPRESS2 8.8% 2.50X8MM DRUG ELUTING STENT IN THE TARGET LESION. THERE WERE NO COMPLICATIONS. THE PATIENT WAS DISCHARGED THE NEXT DAY ON PLAVIX AND ASPIRIN. 246 DAYS AFTER THE INITIAL PROCEDURE, THE PATIENT EXPIRED. THERE WAS NO AUTOPSY, IN THE OPINION OF THE PHYSICIAN THE CAUSE OF DEATH WAS CARDIAC ARREST, CONGESTIBE HEART FAILURE AND CARDIOMYOPATHY. THE RELATIONSHIP OF DEATH TO THE TARGET VESSEL IS UNKNOWN.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 TAXUS EXPRESS2 PACLITAXEL-ELUTING CORONARY STENT DRUG ELUTING STENT NIQ BOSTON SCIENTIFIC 2.50X16MM 6986105

Patients

Seq Age Sex Outcome Treatment
1 32 YR Death